本帖最后由 成长的烦恼 于 2012-6-27 20:19 编辑 4 W1 A/ M1 T2 `& L; c o
2 n; x% e }( v7 Q& uclinicaltrials上的三期临床链接$ d, W9 Q7 m; x# V+ }, [
% {" Y! W) Y: {6 ?" g7 ^http://clinicaltrials.gov/ct2/sh ... mp;show_locs=Y#locn
3 d' E0 ^1 E3 | N" ?: T
3 g7 f) `9 D( w, r中国参加临床实验的城市
3 a+ e: x3 _7 `" u/ ^0 \$ f" `& Q
China, Guangdong $ `3 K" e4 q* @0 m1 c
, t" N% W/ x4 j! lGuangzhou, Guangdong, China, 510515 : ~+ f _% w$ v9 E
; C0 ?( r" [9 q* `* F9 aGuangzhou, Guangdong, China, 510060
3 x+ d+ ~& J5 U# D# l5 fChina, Jiangsu
0 ?4 H% c7 d; t
- Q; B* T2 w8 |2 a) b9 y1 v, YNanjing, Jiangsu, China, 210009
) W! R! c; |# w; c # `. ]7 c$ A# m' u4 x5 p
Nanjing, Jiangsu, China, 210002 + ?. V3 L ]) l/ Y. f# A. v! P
China, Shandong 4 N' T( { q3 ~% o' S6 w
$ H: K# u+ X. v7 p
Qingdao, Shandong, China, 266003 + _; \' P$ {% x$ V' z$ N. Y+ J$ ` X0 Y% ^
China
; G" E3 v" K9 T
$ f% C2 w' x g) @! H$ k" T) ?( vBeijing, China, 100021
" f1 f2 S' u& B, D
; O& v4 ?" V- [" q9 }, l# tBeijing, China, 100071
) a7 ` F. s9 c; o7 ]
/ u! H/ Z- H2 T2 S, nChangchun, China, 130021 6 ]* I& m( q2 B
- X9 s) Y, I! K5 W6 |Chongqing, China, 400042
8 G8 o& d1 H3 |! } # j" o/ Q1 I6 G5 y2 P
Chongqing, China, 400038
( J6 k$ l+ P( J2 _
- Q8 D% [8 t Z- l ?Fuzhou, China, 350014
# Y1 V* [- S" E% ~. ^: X 9 A8 I: V0 f5 K: ^1 v( U
Fuzhou, China, 350025 , ], v: v/ P' Y- a) t7 i V/ Z
+ P( Q0 O' ]3 B k# wHa'erbin, China, 150040
: I5 d4 e# r; q, R0 ^' c3 o 2 n& t' V3 ~0 N+ u1 m% j, G
Hanghzou, China, 310009 ) y# P' c- t5 u( ], X4 z
( T# B6 m; A" i
Shanghai, China, 200001 2 Q* ]& r p8 z' j
) O* @' z* [8 F% x* yShanghai, China, 200030
% F- _( ^8 U& w, k* x5 g 6 {' W6 i3 h0 t! w9 |
Tianjin, China
0 z: m: t6 P5 P7 s4 k. ^2 D: Q" j: `
该实验已停止招募,重新开的临床请见临床专用贴。 |